Stonegate Investment Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
23,149
-4,884
| -17% | -$226K | 0.03% | 171 |
|
|
2025
Q1 | $1.71M | Buy |
28,033
+367
| +1% | +$22.4K | 0.05% | 124 |
|
|
2024
Q4 | $1.56M | Buy |
27,666
+523
| +2% | +$29.6K | 0.04% | 130 |
|
|
2024
Q3 | $1.4M | Buy |
27,143
+25
| +0.1% | +$1.29K | 0.04% | 144 |
|
|
2024
Q2 | $1.13M | Sell |
27,118
-1,454
| -5% | -$60.4K | 0.03% | 160 |
|
|
2024
Q1 | $1.55M | Buy |
28,572
+24
| +0.1% | +$1.3K | 0.05% | 130 |
|
|
2023
Q4 | $1.46M | Sell |
28,548
-11,332
| -28% | -$581K | 0.05% | 136 |
|
|
2023
Q3 | $2.31M | Sell |
39,880
-388
| -1% | -$22.5K | 0.08% | 93 |
|
|
2023
Q2 | $2.58M | Sell |
40,268
-2
| -0% | -$128 | 0.09% | 91 |
|
|
2023
Q1 | $2.79M | Buy |
40,270
+94
| +0.2% | +$6.52K | 0.1% | 89 |
|
|
2022
Q4 | $2.89M | Sell |
40,176
-113
| -0.3% | -$8.13K | 0.12% | 83 |
|
|
2022
Q3 | $2.86M | Buy |
40,289
+212
| +0.5% | +$15.1K | 0.13% | 91 |
|
|
2022
Q2 | $3.09M | Buy |
40,077
+11,693
| +41% | +$900K | 0.14% | 90 |
|
|
2022
Q1 | $2.07M | Sell |
28,384
-561
| -2% | -$41K | 0.07% | 96 |
|
|
2021
Q4 | $1.81M | Buy |
+28,945
| New | +$1.81M | 0.08% | 107 |
|